Fresh Tracks Therapeutics... (FRTX)
NASDAQ: FRTX
· Real-Time Price · USD
0.94
0.00 (0.00%)
At close: Feb 28, 2025, 12:19 PM
Fresh Tracks Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -5.69M | -8.98M | -17.11M | -15.97M | -21.1M | -22.64M | -29.88M | -39.88M | -39.47M | -40.77M | -31.84M | -25.82M |
Depreciation & Amortization | 41K | 40K | 37K | 33K | 30K | 28K | 27K | 28K | 22K | 16K | 12K | 8K |
Stock-Based Compensation | 1.92M | 2.14M | 1.82M | 1.98M | 2.16M | 2.26M | 2.5M | 2.35M | 2.26M | 2.25M | 2.03M | 2.06M |
Other Working Capital | 118K | 2.39M | 3.65M | 2.56M | 556K | -1.42M | -1.89M | -2.3M | -1.58M | 172K | -1.14M | 517K |
Other Non-Cash Items | 60K | 75K | 102K | 98K | 88K | 136K | 2.06M | 1.61M | 4.71M | 5.15M | 3.51M | 4.38M |
Deferred Income Tax | n/a | n/a | n/a | -15K | -29K | -29K | -29K | -14K | n/a | n/a | n/a | n/a |
Change in Working Capital | -669K | 929K | 2.02M | -412K | -478K | -1.31M | -3.14M | -3.89M | -556K | 370K | 794K | 3.93M |
Operating Cash Flow | -4.34M | -5.8M | -13.13M | -14.28M | -19.34M | -21.55M | -28.45M | -39.8M | -36.15M | -36.1M | -28.95M | -19.32M |
Capital Expenditures | n/a | n/a | -47K | -47K | -47K | -47K | n/a | 4K | -36K | -59K | -59K | -63K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 4K | 4K | -19K | -19K | -23K |
Investing Cash Flow | n/a | n/a | -47K | -47K | -47K | -47K | n/a | 4K | -36K | -59K | -59K | -63K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 437K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | -55K | -55K | -55K | -55K | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -38K | -2K | 8K | 37K | -18K | -48K | -48K | -77K | 8.95M | 8.97M | 8.97M | 8.98M |
Financial Cash Flow | 6.53M | 6.57M | 7.64M | 7.8M | 1.18M | 11.47M | 18.52M | 22.3M | 32.95M | 37.37M | 31.85M | 47.03M |
Net Cash Flow | 2.19M | 770K | -5.53M | -6.53M | -18.2M | -10.13M | -9.93M | -17.49M | -3.23M | 1.21M | 2.84M | 27.65M |
Free Cash Flow | -4.34M | -5.8M | -13.17M | -14.33M | -19.38M | -21.6M | -28.45M | -39.79M | -36.18M | -36.16M | -29.01M | -19.38M |